Literature DB >> 9217897

Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study.

K Malmberg1, L Rydén, A Hamsten, J Herlitz, A Waldenström, H Wedel.   

Abstract

OBJECTIVES: We analysed predictors of 1-year mortality following acute myocardial infarction in patients with diabetes mellitus by applying uni- and multivariate statistics on the DIGAMI cohort.
BACKGROUND: Diabetic patients with acute myocardial infarction have a poor prognosis. This may depend on a poor metabolic control, a hypothesis that was tested in DIGAMI, a prospective randomised study. In this trial institution of immediate intensive insulin treatment reduced 1-year mortality by 30%.
METHODS: We recruited 620 diabetic patients with acute myocardial infarction, 314 of whom served as controls, while the remaining 306 patients were treated with an acute insulin-glucose infusion followed by multidose subcutaneous insulin.
RESULTS: Age, previous myocardial damage, duration of the diabetes and previous insulin therapy were significantly related to 1-year mortality, while conventional risk factors lacked independent prognostic weight. Female sex was not linked to mortality when controlling for the confounding effects of other predictors. One of the strongest predictors of a fatal outcome, in particular during the hospital phase, was blood glucose at hospital admission. Beta-blockade appeared to exert a striking, independent secondary-preventive effect.
CONCLUSIONS: It seems that good metabolic control and not conventional risk factors is of major importance for diabetic patients sustaining acute myocardial infarction. Also treatment with beta-blockade seems to be of special importance in this category of patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217897     DOI: 10.1016/s0008-6363(96)00263-5

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  14 in total

Review 1.  Hyperglycaemia: the relation to dyslipidaemia and atherosclerosis.

Authors:  G H Tomkin
Journal:  Ir J Med Sci       Date:  2002 Jul-Sep       Impact factor: 1.568

2.  Insulin-Treated Patients with Diabetes Mellitus Undergoing Emergency Abdominal Surgery Have Worse Outcomes than Patients Treated with Oral Agents.

Authors:  Tobias Haltmeier; Elizabeth Benjamin; Elizabeth Beale; Kenji Inaba; Demetrios Demetriades
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

3.  Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction.

Authors:  Ayse Akincigil; John R Bowblis; Carrie Levin; Saira Jan; Minalkumar Patel; Stephen Crystal
Journal:  J Gen Intern Med       Date:  2007-10-06       Impact factor: 5.128

Review 4.  New insights into insulin: The anti-inflammatory effect and its clinical relevance.

Authors:  Qiang Sun; Jia Li; Feng Gao
Journal:  World J Diabetes       Date:  2014-04-15

Review 5.  Management of Hyperglycemia in Critical Illness: Review of Targets and Strategies.

Authors:  R Pakhetra; M K Garg; K M Suryanarayana
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 6.  Advances in diabetes for the millennium: diabetes and the endothelium.

Authors:  Paresh Dandona; Ahmad Aljada
Journal:  MedGenMed       Date:  2004-09-29

Review 7.  Endothelium, inflammation, and diabetes.

Authors:  Paresh Dandona
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

8.  Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo.

Authors:  Dirk Ebel; Jost Müllenheim; Jan Frässdorf; Andre Heinen; Ragnar Huhn; Thomas Bohlen; Jan Ferrari; Hendrik Südkamp; Benedikt Preckel; Wolfgang Schlack; Volker Thämer
Journal:  Pflugers Arch       Date:  2003-03-26       Impact factor: 3.657

Review 9.  Stress hyperglycemia and enhanced sensitivity to myocardial infarction.

Authors:  Keith A Webster
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

Review 10.  Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.

Authors:  Birgit Fullerton; Klaus Jeitler; Mirjam Seitz; Karl Horvath; Andrea Berghold; Andrea Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2014-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.